Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in shares of Solventum Corporation (NYSE:SOLV - Free Report) by 15.3% during the 3rd quarter, according to the company in its most recent...
MarketBeat·20h ago
More News
Citigroup Inc. Decreases Holdings in Solventum Corporation $SOLV
Citigroup Inc. cut its stake in Solventum Corporation (NYSE:SOLV - Free Report) by 37.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·2d ago
Andra AP fonden Has $8.04 Million Holdings in Solventum Corporation $SOLV
Andra AP fonden grew its position in Solventum Corporation (NYSE:SOLV - Free Report) by 188.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·2d ago
Solventum Q4 Earnings Call Highlights
Solventum (NYSE:SOLV) executives said the company ended fiscal 2025 with solid momentum in its first full year as a standalone public company, pointing to improved organic sales growth, continued...
MarketBeat·2d ago
US Bancorp DE Has $31.04 Million Stock Position in Solventum Corporation $SOLV
US Bancorp DE lowered its stake in Solventum Corporation (NYSE:SOLV - Free Report) by 5.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 425,140...
MarketBeat·3d ago
Solventum (NYSE:SOLV) Rating Increased to Buy at Wall Street Zen
Wall Street Zen raised Solventum from a "hold" rating to a "buy" rating in a research note on Saturday...
MarketBeat·3d ago
Solventum (NYSE:SOLV) Given New $83.00 Price Target at Wells Fargo & Company
Wells Fargo & Company reduced their price objective on shares of Solventum from $86.00 to $83.00 and set an "equal weight" rating for the company in a research note on Friday...
OPKO Health beats Q4 earnings and revenue estimates, but sales decline and gross margin narrows.
Zacks·4d ago
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down
SOLV's Q4 earnings and revenues beat estimates, driven by organic growth across MedSurg, Dental and HIS, despite margins declined.
Zacks·4d ago
Solventum (NYSE:SOLV) Stock Price Expected to Rise, KeyCorp Analyst Says
KeyCorp upped their target price on shares of Solventum from $97.00 to $99.00 and gave the company an "overweight" rating in a research note on Friday...